All Type of News
Atacand Approved for Chronic Heart Failure Treatment
AstraZeneca’s Atacand (candesarten cilexetil), an Angiotensin II Receptor Blocker (ARB) for the treatment of hypertension, has been additionally approved for the treatment of Chronic Heart Failures (CHF) by passing th...
Pantogar Proven Effective from Domestic Clinical Studies
According to the recent domestic clinical studies conducted by Prof. Rho Byung-in of Chung-Ang University Hospital Department of Dermatology, Pantogar has been proven effective for the treatment of female hair loss an...
Drug Validation Guidelines Set by KFDA
In an effort to promote production and manufacture of high-quality drugs by the pharmaceutical companies, the Korea Food and Drug Administration (KFDA) announced that it has established the Guideline for Drug Analytic...
Propacetamol Showed Therapeutic Equivalence for Sulpyrine
Following the KFDA’s ban on the production and sales of drugs containing terfenadine and sulpyrine due to possible harmful side effects, a recent report from the overseas clinical studies is drawing attention on the t...
AstraZeneca Korea Introduces The Zoladex SafeSystem SyringeAstraZeneca Korea announced its introduction of The Zoladex SafeSystem Syringe, which is to improve the overall safety measures commonly associated with the existing syringe dev...
|
Social Disadvantages Towards People with Atopic Dermatitis
According to a recent survey conducted by Prof. Park Chun-uk of the Hallym University, people suffering from atopic dermatitis also experience high level of social disadvantages.
The survey was conducted to 453 pat...
Abbott Korea’s Return Process Clashes with Local Wholesalers
Local drug wholesalers expressed their concerns over Abbott Korea’s handling of its return process by stating that the company is not showing an active measure towards the requested inventory returns.
A representat...
LG Life Sciences Wins Exclusive Marketing Right for AMEVIVE
LG Life Sciences, Ltd. and Biogen Idec Inc., a U.S.-based biotechnology company, have recently agreed to make LG Life Sciences an exclusive marketing partner for sale of Biogen’s AMEVIVE (Alefacept) in Korea.
AMEVI...
Asia Pharmaceuticals Enters Gastric Ulcer Market
Asia Pharmaceuticals (Korean: A-Ju Pharm), via its strategic partnership with Japan’s Kotobuki Pharmaceuticals, enters the domestic gastric ulcer treatment market by launching Azuroxa Granule (Egualen Na 15mg).
Azu...
NHI Reimbursement Price to be set in Early December
The Health Insurance Policy Review Council (HIPRC) announced that the National Health Insurance (NHI) reimbursement and insurance prices are to be finally set upon completing the upcoming meetings scheduled on Decembe...
